Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Toxicol In Vitro ; 29(8): 2001-8, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26319029

RESUMEN

Recent studies suggest that phthalates may have a role in the development of allergic diseases, probably due to an adjuvant effect. The present study aimed to investigate the possible adjuvant effect of dibutyl phthalate (DBP) in two in vitro models of contact-allergen induced cell activation, namely the NCTC 2544 IL-18 assay and the THP-1 activation assay. Results show no adjuvant effect in the human keratinocyte cell line NCTC 2544, indicated by lack of increase in interleukin 18 (IL-18) production after exposure to p-Phenylenediamine (PPD) in association with DBP. On the contrary, increased upregulation of CD86 and interleukin 8 (IL-8) production were observed in THP-1 cells exposed to combinations of citral (Cit) or imidazolidinyl urea (IMZ) with DBP, indicative of an adjuvant effect. Additionally, higher production of reactive oxygen species (ROS) in THP-1 cells treated with DBP associated to Cit supports that oxidative stress could be part of the molecular mechanism of the observed adjuvant effect. In conclusion, we demonstrate that DBP presents in vitro an adjuvant effect for immune stimulation in dendritic cells but not in keratinocytes. Future studies are necessary to elucidate the precise mechanism underlying the adjuvant effect of DBP in vitro and in vivo.


Asunto(s)
Alérgenos/toxicidad , Dibutil Ftalato/toxicidad , Animales , Línea Celular , Supervivencia Celular/efectos de los fármacos , Citocinas/genética , Citocinas/metabolismo , Sinergismo Farmacológico , Regulación de la Expresión Génica/efectos de los fármacos , Regulación de la Expresión Génica/inmunología , Ratones , ARN Mensajero/genética , ARN Mensajero/metabolismo , Especies Reactivas de Oxígeno
2.
Hum Exp Toxicol ; 33(1): 54-63, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23536518

RESUMEN

It has been hypothesized that oils containing high levels of omega-3 polyunsaturated fatty acids, such as canola and fish oil, could counteract some of the adverse effects induced by phthalates. In the present study, the influence of different oily vehicles on di-butyl phthalate (DBP)-induced testicular toxicity and lipid profile was investigated. Pregnant Wistar rats were treated by oral gavage from gestation days 13 to 20 with DBP (500 mg/kg/day) diluted in three different vehicles: corn, canola or fish oil. Male fetuses were analyzed on gestation day 20. DBP exposure lowered intratesticular testosterone levels and anogenital distance, regardless of the vehicle used. The percentage of seminiferous cords containing multinucleated gonocytes and cord diameter was increased in DBP-exposed groups, compared with vehicle controls, with no difference between the three DBP-exposed groups. Clustering of Leydig cells was seen in all DBP groups. Lipid profile indicated that administration of canola and fish oil can increase the content of omega-3 fatty acids in rat testis. However, content of omega-3 was diminished in DBP-treated groups. Overall, our results indicate that different oily vehicles did not alter fetal rat testicular toxicity induced by a high DBP dose.


Asunto(s)
Dibutil Ftalato/toxicidad , Disruptores Endocrinos/toxicidad , Ácidos Grasos Omega-3/metabolismo , Metabolismo de los Lípidos/efectos de los fármacos , Exposición Materna/efectos adversos , Vehículos Farmacéuticos/metabolismo , Testículo/efectos de los fármacos , Animales , Aceite de Maíz/química , Aceite de Maíz/metabolismo , Dibutil Ftalato/administración & dosificación , Disruptores Endocrinos/administración & dosificación , Contaminantes Ambientales/administración & dosificación , Contaminantes Ambientales/toxicidad , Ácidos Grasos Monoinsaturados/química , Ácidos Grasos Monoinsaturados/metabolismo , Ácidos Grasos Omega-3/química , Femenino , Desarrollo Fetal/efectos de los fármacos , Aceites de Pescado/química , Aceites de Pescado/metabolismo , Masculino , Vehículos Farmacéuticos/química , Plastificantes/administración & dosificación , Plastificantes/toxicidad , Embarazo , Aceite de Brassica napus , Ratas , Procesos de Determinación del Sexo/efectos de los fármacos , Testículo/embriología , Testículo/metabolismo , Testosterona/metabolismo
3.
Hum Exp Toxicol ; 32(9): 930-41, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23424214

RESUMEN

Artemisinins combination therapy (ACT) is the first choice therapy for falciparum malaria. Data on the safety of ACTs in pregnancy are limited and controversial and the use is not recommended on the first trimester. To evaluate the effects of isolated and combined artesunate (AS)/mefloquine (MQ) on embryo rats, pregnant rats were treated orally with AS (15 and 40 mg/kg body weight (bwt)/day), MQ (30 and 80 mg/kg bwt/day) and AS/MQ (15/30 and 40/80 mg/kg bwt/day) on days 9-11 post coitum (pc). The dams were euthanized on day 12 pc and gestational and embryos histological parameters were evaluated. Embryolethality and histopathological anomalies were significant when AS was given alone or combined with MQ. Combination of AS and MQ did not enhance their toxicity compared to their separate administrations; on the other side, there was a reduction in the toxic effects of the AS when combined with MQ. Isolated MQ did not induce developmental toxicity.


Asunto(s)
Antimaláricos/toxicidad , Artemisininas/toxicidad , Embrión de Mamíferos/efectos de los fármacos , Desarrollo Embrionario/efectos de los fármacos , Exposición Materna/efectos adversos , Mefloquina/toxicidad , Animales , Antimaláricos/administración & dosificación , Artemisininas/administración & dosificación , Artesunato , Relación Dosis-Respuesta a Droga , Quimioterapia Combinada , Pérdida del Embrión/inducido químicamente , Pérdida del Embrión/metabolismo , Pérdida del Embrión/patología , Embrión de Mamíferos/metabolismo , Embrión de Mamíferos/patología , Femenino , Mefloquina/administración & dosificación , Embarazo , Ratas , Ratas Wistar
4.
J Nanosci Nanotechnol ; 10(4): 2669-73, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20355482

RESUMEN

Zinc oxide nanowires have been grown on alumina substrate by thermal evaporation of zinc nanopowder in the presence of oxygen flow. The growth was performed under ambient pressure and without the use of foreign catalyst. Scanning electron microscopy (SEM) observation showed that the as-grown sample consists of bulk ZnO crystal on the substrate surface with nanowires growing from this base. Growth mechanism of the observed morphology is suggested to be governed by the change of zinc vapour supersaturation during the growth process. X-ray diffraction (XRD) measurement was used to identify the crystalline phase of the nanowires. Optical properties of the nanowires were investigated using Raman scattering and photoluminescence (PL). The appearance of dominant, Raman active E2 (high) phonon mode in the Raman spectrum has confirmed the wurtzite hexagonal phase of the nanowires. With above bandgap excitation the low temperature PL recombination is dominated by donor bound exciton luminescence at -3.37 eV with a narrow full width at half maximum. Free exciton emission is also seen at low temperature and can be observed up to room temperature. The optical data indicates that the grown nanowires have high optical quality.

5.
Acta Neurol Scand ; 100(1): 61-3, 1999 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10416513

RESUMEN

OBJECTIVE: To investigate the lipoprotein profile in a group of Alzheimer's disease (AD) patients. PATIENTS AND METHODS: Twenty-four patients with AD and 32 elderly controls were evaluated. Fasting blood samples were obtained for determination of total VLDL, HDL and LDL cholesterol, lipoprotein (a), triglycerides, apolipoprotein A1 and apolipoprotein B. RESULTS: Significantly higher levels of apolipoprotein B were found in AD patients (P = 0.004), whereas the concentration of lipoprotein (a) and plasma lipids was not statistically different. Apo B levels were similar between AD patients with or without leukoaraiosis on CT scan. CONCLUSION: AD patients had high serum concentration of apolipoprotein B. This finding suggests that apolipoprotein E may not be the single factor in lipid metabolism to play a role in AD pathogenesis.


Asunto(s)
Enfermedad de Alzheimer/sangre , Apolipoproteínas B/sangre , Anciano , Enfermedad de Alzheimer/diagnóstico , Encéfalo/diagnóstico por imagen , Infarto Cerebral/diagnóstico , HDL-Colesterol/sangre , LDL-Colesterol/sangre , VLDL-Colesterol/sangre , Femenino , Humanos , Masculino , Tomografía Computarizada por Rayos X
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...